Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry:

Stéphane Zuily,Isabelle Clerc-Urmès,Cédric Bauman,Danieli Andrade,Savino Sciascia,Vittorio Pengo,Maria G. Tektonidou,Amaia Ugarte,Maria Gerosa,H. Michael Belmont,María Ángeles Aguirre-Zamorano,Paul R. Fortin,L. Ji,M Efthymiou,Hannah Cohen,D. Ware Branch,Guilherme Ramires de Jesus,Cecilia Nalli,Michelle Petri,Esther Rodríguez,Ricard Cervera,Jason S. Knight,Tatsuya Atsumi,Rohan Willis,Maria Laura Bertolaccini,JoAnn Vega,Denis Wahl,Doruk Erkan,Aps Action Investigators

Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry:

2020

ObjectiveThis study aimed to use cluster analysis (CA) to identify different clinical phenotypes among antiphospholipid antibodies (aPL)-positive patients.MethodsThe Alliance for Clinical Trials an...

Keywords:

Phenotype
Antiphospholipid syndrome
Clinical trial
Internal medicine
Antibody
cardiovascular risk factors
Medicine
Immunology
Diabetes mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations